BioSpace News Archive

VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI” or the “Company”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the voting results from its annual general meeting of shareholders held on June 18, 2020 (the “Meeting”).

Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB: ASPF) today announced that it has commenced litigation against Recipharm Limited (“Recipharm”), a wholly-owned subsidiary of Recipharm AB (RECI-B.ST), in the Commercial Court of London. Acerus alleges that the suspension of Recipharm’s manufacturing lice

Patterson Companies announced that it will hold its fiscal 2020 fourth-quarter and year end conference call on Wednesday, June 24, 2020 at 9 a.m. CT.

Repare Therapeutics Inc., a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics, announced the pricing of its upsized initial public offering of 11,000,000 of its common shares at a public offering price of $20.00 per share.

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing treatments for serious and orphan diseases, today announced that it will host a webcast investor event on July 9, 2020 from 8:15 a.m. to 9:30 a.m. Eastern Time.

Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced that the Company will regain worldwide rights to all microbiome gastrointestinal programs licensed under its collaboration agreement with AbbVie

Arena Pharmaceuticals, Inc. announced that on June 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 80,250 shares of its common stock to 12 new employees and 12,360 inducement restricted stock units to 11 new employees.

Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (“KORU Medical”) today announced that it has commenced an underwritten public offering of the sale of its shares of common stock

Owens & Minor, Inc. announced the completion of the sale of its European logistics business, Movianto, to EHDH Holding Group, one of Europe’s leading providers of healthcare logistics.

The Karen Toffler Charitable Trust is pleased to announce the public launch of its newly expanded organization.